Scilex Holding Company面临Nasdaq因丢失Q3 2024财务报告截止日期而未遵守规定的情况。 Scilex Holding Company faces Nasdaq non-compliance for missing Q3 2024 financial report deadline.

一家加利福尼亚公司Scilex Holding Company, 专注于非类阿片止痛治疗,收到了Nasdaq的通知,称该公司没有提交Q3 2024财务报告,导致不遵守列名规则。 Scilex Holding Company, a California firm focused on non-opioid pain treatments, received a notice from Nasdaq for not filing its Q3 2024 financial report, leading to non-compliance with listing rules. 该公司必须在2025年1月20日之前提交恢复履约计划,如果该计划被接受,可延长至2025年7月20日。 The company has until January 20, 2025, to submit a plan for regaining compliance, with a possible extension to July 20, 2025, if the plan is accepted. Scilex打算尽快将报告归档。 Scilex intends to file the report as soon as possible.